Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARINE: Vascepa in Severe Hypertriglyceridemia
NCT01047683Phase 3Completed
- Sponsor
- Amarin Corporation plc
- Start
- Dec 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of omega-3 long-chain polyunsaturated fatty acids in hypertriglyceridemia, sponsored by Amarin Corporation plc. Started Dec 2009; status: completed.
02
Drugs
omega-3 long-chain polyunsaturated fatty acids
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01047683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047683.